Use of Protein Tyrosine Inhibitor Such As Genistein in Treating Diabetic Retinopathy Or Ocular Inflammation
PROBLEM TO BE SOLVED: To provide a method for prophylactically and therapeutically treating diabetic retinopathy and a method for prophylactically and therapeutically treating ocular inflammation. ; SOLUTION: Administration of an inhibitor of the protein tyrosine kinase pathway to an animal (e.g. a mammal, particularly a human) in an amount sufficient to treat diabetic retinopathy or ocular inflammation is provided. The inhibitor of the protein tyrosine kinase pathway is preferably genistein or an analogue or prodrug thereof or a pharmaceutically acceptable salt of any of the foregoing. ; COPYRIGHT: (C)2010,JPO&INPIT
Patents:JP 2,010,168,389
Inventor(s):
DE JUAN EUGENE JR
Type of Offer:
Licensing
« More Biotech Patents